Form 4: Director Ceccoli Granted 22,511 Shares in Applied DNA Sciences
Insider Transaction Report
Applied DNA Sciences Director Joseph D. Ceccoli was granted 22,511 restricted stock units, increasing his beneficial ownership to 22,512 shares.
Summary
- Joseph D. Ceccoli, a Director of Applied DNA Sciences Inc. (BNBX), acquired 22,511 shares of common stock.
- The acquisition was in the form of restricted stock units (RSUs) with a transaction price of $0 per share.
- Following this transaction, Mr. Ceccoli beneficially owns a total of 22,512 shares of common stock.
- The restricted stock units are scheduled to vest 100% upon 90 days from the grant date of October 17, 2025.
Sentiment
Score: 6
Explanation: Slightly positive as it indicates increased insider ownership and alignment of interests, though it's a routine compensation event rather than a significant strategic or financial announcement.
Positives
- The grant of restricted stock units to a director increases their beneficial ownership, potentially aligning their interests more closely with those of shareholders.
Future Outlook
The granted restricted stock units are expected to vest 100% approximately 90 days from the grant date of October 17, 2025, which would be around January 15, 2026.
Related Party Transactions
- The grant of restricted stock units to Joseph D. Ceccoli, a Director, constitutes a related party transaction between the company and its board member as part of his compensation.
Stakeholder Impact
- Shareholders: Increased director ownership may signal greater alignment of interests between management and shareholders.
- Director: Joseph D. Ceccoli's equity stake in the company has increased, tying his personal financial interests more closely to the company's performance.
Next Steps
- The restricted stock units will vest 90 days from the grant date, at which point the shares will become fully owned by the director.
Key Dates
| Date | Description |
|---|---|
| 10/17/2025 | Date of earliest transaction (grant date of restricted stock units). |
| 10/20/2025 | Signature date of the reporting person's attorney-in-fact. |
| 01/15/2026 | Estimated vesting date for 100% of the restricted stock units (90 days from grant date). |
Keywords
Applied DNA Sciences, BNBX, Joseph D. Ceccoli, Director, Restricted Stock Units, RSU Grant, Insider Ownership, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.